Literature DB >> 29759519

Mitigating Post-Extraction Risk: Is it Worth the inVESTment?

Mina K Chung1.   

Abstract

Entities:  

Keywords:  cardiac device infection; implantable cardioverter-defibrillator; sudden cardiac arrest; ventricular arrhythmia; wearable cardioverter-defibrillator

Mesh：

Year:  2016        PMID： 29759519      PMCID： PMC6459686          DOI： 10.1016/j.jacep.2016.10.015

Source DB:  PubMed          Journal:  JACC Clin Electrophysiol        ISSN： 2405-500X


× No keyword cloud information.
  8 in total

1.  Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).

Authors:  Valentina Kutyifa; Arthur J Moss; Helmut Klein; Yitschak Biton; Scott McNitt; Bonnie MacKecknie; Wojciech Zareba; Ilan Goldenberg
Journal:  Circulation       Date:  2015-08-27       Impact factor: 29.690

2.  Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival.

Authors:  Mina K Chung; Steven J Szymkiewicz; Mingyuan Shao; Edwin Zishiri; Mark J Niebauer; Bruce D Lindsay; Patrick J Tchou
Journal:  J Am Coll Cardiol       Date:  2010-07-13       Impact factor: 24.094

Review 3.  Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death: A Science Advisory From the American Heart Association.

Authors:  Jonathan P Piccini; Larry A Allen; Peter J Kudenchuk; Richard L Page; Manesh R Patel; Mintu P Turakhia
Journal:  Circulation       Date:  2016-03-28       Impact factor: 29.690

4.  Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator.

Authors:  Edwin T Zishiri; Sarah Williams; Edmond M Cronin; Eugene H Blackstone; Stephen G Ellis; Eric E Roselli; Nicholas G Smedira; A Marc Gillinov; Jo Ann Glad; Patrick J Tchou; Steven J Szymkiewicz; Mina K Chung
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-12-28

5.  Benefit of the Wearable Cardioverter-Defibrillator in Protecting Patients After Implantable-Cardioverter Defibrillator Explant: Results From the National Registry.

Authors:  Kenneth A Ellenbogen; Jayanthi N Koneru; Parikshit S Sharma; Sanjay Deshpande; Chingping Wan; Steven J Szymkiewicz
Journal:  JACC Clin Electrophysiol       Date:  2016-11-23

6.  Prognostic importance of defibrillator shocks in patients with heart failure.

Authors:  Jeanne E Poole; George W Johnson; Anne S Hellkamp; Jill Anderson; David J Callans; Merritt H Raitt; Ramakota K Reddy; Francis E Marchlinski; Raymond Yee; Thomas Guarnieri; Mario Talajic; David J Wilber; Daniel P Fishbein; Douglas L Packer; Daniel B Mark; Kerry L Lee; Gust H Bardy
Journal:  N Engl J Med       Date:  2008-09-04       Impact factor: 91.245

7.  Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction.

Authors:  Andrew E Epstein; William T Abraham; Nicole R Bianco; Karl B Kern; Michael Mirro; Sunil V Rao; Edward K Rhee; Scott D Solomon; Steven J Szymkiewicz
Journal:  J Am Coll Cardiol       Date:  2013-07-31       Impact factor: 24.094

8.  Reduction in inappropriate therapy and mortality through ICD programming.

Authors:  Arthur J Moss; Claudio Schuger; Christopher A Beck; Mary W Brown; David S Cannom; James P Daubert; N A Mark Estes; Henry Greenberg; W Jackson Hall; David T Huang; Josef Kautzner; Helmut Klein; Scott McNitt; Brian Olshansky; Morio Shoda; David Wilber; Wojciech Zareba
Journal:  N Engl J Med       Date:  2012-11-06       Impact factor: 91.245
  8 in total
  1 in total

1.  Delayed Improvement of Left Ventricular Function in Newly Diagnosed Heart Failure Depends on Etiology-A PROLONG-II Substudy.

Authors:  Johanna Mueller-Leisse; Johanna Brunn; Christos Zormpas; Stephan Hohmann; Henrike Aenne Katrin Hillmann; Jörg Eiringhaus; Johann Bauersachs; Christian Veltmann; David Duncker
Journal:  Sensors (Basel)       Date:  2022-03-05       Impact factor: 3.576
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.